Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mass Spectrometry Detection of Drugs in Single Bladder Cancer Cells From Patients

NCT03639090 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT03639090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03639090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mass Spectrometry Detection of Drugs in Single Bladder Cancer Cells From Patients
Lead sponsor
University of Oklahoma
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
October 8, 2020
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer